Fundraising Fox1nhaler
1 known investors
Find your way into 1nhaler
Sign up to see every warm intro you have to 1nhaler
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 1nhaler team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines. Its lead project is a salbutamol inhaler for asthma relief, with potential applications in rescue medications, anaphylaxis, migraine, vaccines and clinical trials.
Founders & leadership
HM
Helen MuirheadChief Scientific Officer
LL
Lars LarssonChief Medical Officer
Investors · 1
Archangelslisted by ArchangelsEdinburgh
How we know: archangelsonline.com · funding news · Not right? Tell us
Frequently asked questions
- What does 1nhaler do?
- 1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines. Its lead project is a salbutamol inhaler for asthma relief, with potential applications in rescue medications, anaphylaxis, migraine, vaccines and clinical trials.
- Who are 1nhaler's investors?
- 1nhaler's investors include Archangels.